Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831085 · ClinicalTrials.gov registry record · NA
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
A NA study of Coronary Artery Stenosis, sponsored by Duk-Woo Park, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 20
- Study locations
NCT05831085: Recruiting NA study of Coronary Artery Stenosis, sponsored by Duk-Woo Park, MD.
NCT05831085 is a NA study of Coronary Artery Stenosis that is actively recruiting participants, run by Duk-Woo Park, MD. The registered enrollment target is 1,500 participants, above the 1,292-participant average among 4 other Coronary Artery Stenosis trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05831085, a NA study of Coronary Artery Stenosis, is actively recruiting participants, sponsored by Duk-Woo Park, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this randomized study was to compare outcomes of imaging-and physiology-guided state-of-the-art percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) in patients with diabetes and three-vessel CAD (not involving left main).
Primary Outcome
Major adverse cardiac or cerebrovascular events (MACCE) were defined as a composite of hard clinical endpoints of death from any causes, myocardial infarction, or stroke.
Conditions Studied
Interventions
- PROCEDURE State-of-the-Art Percutaneous Coronary Intervention
- PROCEDURE standard CABG
Study Locations (20)
Other
- Fuwai Hospital, Chinese Academy of Medical Sciences (CAMS) - Beijing
- Second Affiliated Hospital of Zhejiang University School of Medicine - Hanzhou
- Medanta - The Medicity - Gurugram
- Fortis Escorts Heart Institute - New Delhi
- Sarawak Heart Centre - Kota Samarahan
- University Clinical Center of Serbia - Belgrade
- National Heart Centre Singapore (NHCS) - Singapore
- Daegu Catholic University Medical Center - Daegu
- Keimyung University Dongsan Medical Center - Daegu
- Yeungnam University Medical Center - Daegu
- Chungnam National University Hospital - Daejeon
- Konyang University Hospital - Daejeon
- Gangneung Asan Hospital - Gangneung
- Chonnam National University Hospital - Gwangju
- National Health Insurance Service Ilsan Hospital - Ilsan
- Gachon University Gil Hospital - Incheon
- Dong-A Medical Center - Pusan
- Asan Medical Center - Seoul
- Hanyang University Seoul Hospital - Seoul
California
- Palo Alto VA Medical Center - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05831085 shows while recruiting
NCT05831085 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,292-participant average among 4 other Coronary Artery Stenosis trials with a reported enrollment target (16% higher).
The record links to 1 condition, with Coronary Artery Stenosis appearing as the primary indexed condition, and to 2 interventions - of which State-of-the-Art Percutaneous Coronary Intervention is the first listed.
NCT05831085 names 20 study sites across 2 states, led by Other, California.
Frequently Asked Questions
What is clinical trial NCT05831085 about?
NCT05831085 is a clinical study titled "Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease". The objective of this randomized study was to compare outcomes of imaging-and physiology-guided state-of-the-art percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) in patients with diabetes and three-vessel CAD (not involving left main).
What is the current status of trial NCT05831085?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2024-06-14. Estimated completion is 2027-12.
What conditions does trial NCT05831085 study?
This clinical trial studies the following conditions: Coronary Artery Stenosis.
What interventions are being tested in trial NCT05831085?
The interventions under investigation include: State-of-the-Art Percutaneous Coronary Intervention (PROCEDURE), standard CABG (PROCEDURE).
Who is sponsoring clinical trial NCT05831085?
This trial is sponsored by Duk-Woo Park, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05831085 being conducted?
This trial has 20 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
COMPLETED · NA
-
Kidney Damage in Patients With Normal eGFR
COMPLETED · Phase 4
-
A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions
COMPLETED
-
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI